EdgarLookup

CTT PHARMACEUTICAL HOLDINGS, INC. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Bowes Gregory B. CEO/CFO Other 500,000 $0.01 $5,000 10,070,000 May 22, 2014
Birge William Campbell Option Exercise 112,500 $0.30 $33,750 402,250 Jan 4, 2012
Bowes Gregory B. CEO and CFO Option Exercise 225,000 $0.30 $67,500 575,000 Dec 22, 2011
Bowes Gregory B. President, CEO and CFO Award / Grant 2,500,000 4,500,000 Sep 28, 2010
Birge William Campbell Award / Grant 2,250,000 $0.02 $45,000 2,250,000 Sep 20, 2010
DINNING ROBERT G CFO Award / Grant 2,000,000 2,000,000 Sep 9, 2008
Cooper Paul K Chief Operating Officer Purchase 20,000 $0.24 $4,800 20,000 Nov 21, 2007
Wodar David John President, CEO Gift 100,000 900,000 Nov 6, 2007
VAN TOL LARRY President and CEO Purchase 5,000,000 $0.30 $1,500,000 5,652,250 Apr 24, 2006